Rinat Yerushalmi
Overview
Explore the profile of Rinat Yerushalmi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
4655
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alvarez-Elizondo M, Raiter A, Yerushalmi R, Weihs D
Ann Biomed Eng
. 2025 Jan;
PMID: 39757331
Metastasis remains the leading cause (90%) of cancer-related mortality, especially in metastatic triple-negative breast cancer (TNBC). Improved understanding of molecular drivers in the metastatic cascade is crucial, to find accurate...
2.
Raiter A, Barhum Y, Lipovetsky J, Menachem C, Elgavish S, Ruppo S, et al.
Neoplasia
. 2024 Dec;
60:101117.
PMID: 39729650
Triple-negative breast cancer (TNBC) is an aggressive subtype that accounts for 10-15 % of breast cancer. Current treatment of high-risk early-stage TNBC includes neoadjuvant chemo-immune therapy. However, the substantial variation...
3.
Goldvaser H, Yerushalmi R, Mutai R, Kuchuk I, Toker M, Paluch-Shimon S, et al.
Breast Cancer Res Treat
. 2024 Nov;
210(1):167-177.
PMID: 39560822
Purpose: To evaluate the association between the HER2 score as provided by the Oncotype DX Recurrence Score (RS) assay, tumor characteristics, and outcomes in early-stage, ER + HER2-negative breast cancer...
4.
Rotem O, Geiger K, Hanovich E, Moskovitz M, Kurman N, Reinhorn D, et al.
Oncol Rev
. 2024 Jun;
18:1355256.
PMID: 38855534
As clinical trials in oncology require substantial efforts, maximizing the insights gained from them by conducting subgroup analyses is often attempted. The goal of these analyses is to identify subgroups...
5.
Fehm T, Cottone F, Dunton K, Andre F, Krop I, Park Y, et al.
Lancet Oncol
. 2024 May;
25(5):614-625.
PMID: 38697155
Background: In DESTINY-Breast02, patients with HER2-positive unresectable or metastatic breast cancer who received trastuzumab deruxtecan demonstrated superior progression-free and overall survival compared with those receiving treatment of physician's choice. We...
6.
Yerushalmi R, Pomerantz A, Lewin R, Paluch-Shimon S, Soussan-Gutman L, Baehner F, et al.
Breast Cancer Res Treat
. 2024 Apr;
206(1):67-76.
PMID: 38568368
Purpose: We compared 21-gene recurrence score (RS) distribution and expression of the single-gene/gene groups within this assay between BC patients with pathogenic variants (PV) in BRCA1/2 vs the general 21-gene-tested...
7.
Ben-Zion Berliner M, Yust-Katz S, Lavie I, Goldberg Y, Kedar I, Yerushalmi R
BMC Cancer
. 2024 Feb;
24(1):219.
PMID: 38365640
Background: Breast cancer is a common cause for central nervous system (CNS) metastasis, resulting in a significant reduction in overall survival. Germline pathogenic variants (PVs) in BRCA1/2 are the most...
8.
Mutai R, Kuchuk I, Goldshtein A, Yerushalmi R, Rotem O, Lotan A, et al.
Breast Cancer Res Treat
. 2024 Feb;
205(2):241-248.
PMID: 38345692
Background: Whether germline BRCA (gBRCA) pathogenic variants (PV) affect prognosis of women with triple negative breast cancer (TNBC) and whether it has implications for treatment decisions in the neoadjuvant setting...
9.
Lambertini M, Blondeaux E, Agostinetto E, Hamy A, Kim H, Di Meglio A, et al.
JAMA
. 2023 Dec;
331(1):49-59.
PMID: 38059899
Importance: Young women with breast cancer who have germline pathogenic variants in BRCA1 or BRCA2 face unique challenges regarding fertility. Previous studies demonstrating the feasibility and safety of pregnancy in...
10.
Shachar S, Leviov M, Yerushalmi R, Drumea K, Tokar M, Soussan-Gutman L, et al.
NPJ Breast Cancer
. 2023 Sep;
9(1):79.
PMID: 37775723
Data on using the 21-gene Recurrence Score (RS) testing on second breast cancer (BC; second primary or local recurrence) are lacking. This cohort study examined patients with first and second...